IWA
BIIB icon

Icon Wealth Advisors’s Biogen BIIB Stock Holding History

Icon Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-774
Closed -$167K – 443
2024
Q1 		$167K Sell
774
-58
-7% -$13.6K 0.02% 368
2023
Q4 		$215K Buy
+832
New +$204K 0.02% 313
2022
Q4 		$308K Sell
1,113
-182
-14% -$51.4K 0.04% 250
2022
Q3 		$346K Buy
+1,295
New +$275K 0.04% 221

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Icon Wealth Advisors's BIIB Position: Q2 2024 in Review

Icon Wealth Advisors sold out of Biogen (BIIB) in Q2 2024, closing a stake of 774 shares — an estimated $167K sold.

Icon Wealth Advisors first reported a position in BIIB in Q3 2022 and held it in 4 quarters. The position peaked at $346K in Q3 2022. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Icon Wealth Advisors reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Icon Wealth Advisors sold 774 Biogen shares in Q2 2024, an estimated $167K.
  • Icon Wealth Advisors first reported a position in Biogen in Q3 2022 and held it in 4 quarters.
  • Icon Wealth Advisors's Biogen position peaked at $346K in Q3 2022.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Icon Wealth Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.